AbbVie | 销售和管理费用



Selling And Administration Expenses 更改 日
AbbVie USD 3.86B 306M 2024-12
Abbott USD 2.91B 21M 2024-12
ALKERMES USD 146.99M 3.39M 2024-12
Amgen USD 1.88B 253M 2024-12
AstraZeneca USD 5.55B 307M 2024-12
Biogen USD 677.3M 99.6M 2024-12
BioMarin Pharmaceutical USD 256.77M 46.81M 2024-12
Bristol-Myers Squibb USD 2.1B 129M 2024-12
Eisai JPY 104.52B 7.1B 2024-12
Eli Lilly USD 2.42B 324.7M 2024-12
Gilead Sciences USD 1.86B 451M 2024-12
GlaxoSmithKline GBP 2.66B 1.14B 2024-12
J&J USD 6.45B 975M 2024-12
Medtronic USD 2.72B 34M 2025-01
Merck USD 2.85B 148M 2024-12
Neurocrine Biosciences USD 287.8M 53.5M 2024-12
Novartis USD 3.5B 368M 2024-12
Pacira USD 79.61M 5.28M 2024-12
Perrigo USD 234.8M 36.7M 2024-12
Pfizer USD 4.27B 1.06B 2024-12
Regeneron Pharmaceuticals USD 792.2M 77.8M 2024-12
Roche Holding CHF 3.61B 381M 2024-12
Sanofi EUR 2.68B 26M 2024-09
UCB EUR 533M 434M 2024-06
Ultragenyx Pharmaceutical USD 82.49M 2.14M 2024-12
United Therapeutics USD 162.5M 8.4M 2024-12
Vertex Pharmaceuticals USD 377.6M 5.8M 2024-12
Zoetis USD 625M 60M 2024-12



AbbVie 销售和管理费用 - 当前值，历史数据，预测，统计，图表和经济日历 - Mar 2025.